Cargando…

Local and Systemic RAGE Axis Changes in Pulmonary Hypertension: CTEPH and iPAH

OBJECTIVE: The molecular determinants of chronic thromboembolic pulmonary hypertension (CTEPH) and idiopathic pulmonary arterial hypertension (iPAH) remain poorly understood. The receptor for advanced glycation endproducts (RAGE) and its ligands: HMGB1 and S100A9 are involved in inflammatory disorde...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moser, Bernhard, Megerle, Anna, Bekos, Christine, Janik, Stefan, Szerafin, Tamás, Birner, Peter, Schiefer, Ana-Iris, Mildner, Michael, Lang, Irene, Skoro-Sajer, Nika, Sadushi-Kolici, Roela, Taghavi, Shahrokh, Klepetko, Walter, Ankersmit, Hendrik Jan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4154707/ https://www.ncbi.nlm.nih.gov/pubmed/25188497 http://dx.doi.org/10.1371/journal.pone.0106440

Ejemplares similares

Surgical specimens, haemodynamics and long-term outcomes after pulmonary endarterectomy
por: Skoro-Sajer, Nika, et al.
Publicado: (2014)

Expression of RAGE and HMGB1 in Thymic Epithelial Tumors, Thymic Hyperplasia and Regular Thymic Morphology
por: Moser, Bernhard, et al.
Publicado: (2014)

Variation of PetCO(2) during incremental exercise and severity of IPAH and CTEPH
por: Sun, Xingxing, et al.
Publicado: (2022)

Subcutaneous treprostinil in congenital heart disease-related pulmonary arterial hypertension
por: Skoro-Sajer, Nika, et al.
Publicado: (2018)

Current strategies for managing chronic thromboembolic pulmonary hypertension: results of the worldwide prospective CTEPH Registry
por: Guth, Stefan, et al.
Publicado: (2021)

EGR1 Is Implicated in Right Ventricular Cardiac Remodeling Associated with Pulmonary Hypertension
por: Laggner, Maria, et al.
Publicado: (2022)

Real-World Switching to Riociguat: Management and Practicalities in Patients with PAH and CTEPH
por: Gall, Henning, et al.
Publicado: (2018)

Switching to riociguat: a potential treatment strategy for the management of CTEPH and PAH
por: Benza, Raymond L., et al.
Publicado: (2020)

The Roles of S100A4 and the EGF/EGFR Signaling Axis in Pulmonary Hypertension with Right Ventricular Hypertrophy
por: Laggner, Maria, et al.
Publicado: (2022)

Haemodynamic effects of riociguat in CTEPH and PAH: a 10-year observational study
por: Yang, Suqiao, et al.
Publicado: (2021)

Differences in right ventricular function and response to targeted therapy between patients with IPAH and PAH-CHD
por: Zhu, Tengteng, et al.
Publicado: (2023)

HSP27 and 70 expression in thymic epithelial tumors and benign thymic alterations: diagnostic, prognostic and physiologic implications
por: Janik, S., et al.
Publicado: (2016)

Switching from sildenafil to riociguat for the treatment of PAH and inoperable CTEPH: Real-life experiences
por: Andersen, Asger, et al.
Publicado: (2017)

The risk profile change in patients with severe chronic thromboembolic pulmonary hypertension treated with subcutaneous treprostinil
por: Jansa, Pavel, et al.
Publicado: (2023)

Treprostinil for pulmonary hypertension
por: Skoro-Sajer, Nika, et al.
Publicado: (2008)

Follistatin impacts Tumor Angiogenesis and Outcome in Thymic Epithelial Tumors
por: Janik, Stefan, et al.
Publicado: (2019)

Riociguat dose titration in patients with chronic thromboembolic pulmonary hypertension (CTEPH) or pulmonary arterial hypertension (PAH)
por: Ghofrani, Hossein A, et al.
Publicado: (2009)

Heat shock protein 90α in thymic epithelial tumors and non-thymomatous myasthenia gravis
por: Thanner, Jürgen, et al.
Publicado: (2020)

Non-professional marathon running: RAGE axis and ST2 family changes in relation to open-window effect, inflammation and renal function
por: Bekos, Christine, et al.
Publicado: (2016)

Neutrophil extracellular traps and monocyte subsets at the culprit lesion site of myocardial infarction patients
por: Mangold, Andreas, et al.
Publicado: (2019)

Elevated CRP levels predict poor outcome and tumor recurrence in patients with thymic epithelial tumors: A pro- and retrospective analysis
por: Janik, Stefan, et al.
Publicado: (2017)

Riociguat in Patients with CTEPH and Advanced Age and/or Comorbidities
por: Barnikel, Michaela, et al.
Publicado: (2022)

NOVEL CTEPH MIMICKERS IN THE COVID-19 ERA
por: Pietrowicz, Rylie, et al.
Publicado: (2022)

Inhibition of KIF23 Alleviates IPAH by Targeting Pyroptosis and Proliferation of PASMCs
por: Wu, Zeang, et al.
Publicado: (2022)

Symptoms, impacts, and suitability of the Pulmonary Arterial Hypertension – Symptoms and Impact (PAH-SYMPACT™) questionnaire in patients with chronic thromboembolic pulmonary hypertension (CTEPH): a qualitative interview study
por: Currie, Brooke, et al.
Publicado: (2021)

Central versus Peripheral CTEPH—Clinical and Hemodynamic Specifications
por: Kaldararova, Monika, et al.
Publicado: (2022)

Exercise-induced bronchoconstriction, temperature regulation and the role of heat shock proteins in non-asthmatic recreational marathon and half-marathon runners
por: Bekos, Christine, et al.
Publicado: (2019)

Publisher Correction: Exercise-induced bronchoconstriction, temperature regulation and the role of heat shock proteins in non-asthmatic recreational marathon and half-marathon runners
por: Bekos, Christine, et al.
Publicado: (2019)

Ambrisentan for treatment of inoperable chronic thromboembolic pulmonary hypertension (CTEPH)
por: Escribano-Subias, Pilar, et al.
Publicado: (2019)

Epidemiology of chronic thromboembolic pulmonary hypertension (CTEPH) in the Czech Republic
por: Jansa, Pavel, et al.
Publicado: (2022)

Prognostic and diagnostic impact of fibrinogen, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio on thymic epithelial tumors outcome
por: Janik, Stefan, et al.
Publicado: (2018)

Clinical prognostic scores for patients with thymic epithelial tumors
por: Veraar, Cecilia, et al.
Publicado: (2019)

Shigella IpaH Family Effectors as a Versatile Model for Studying Pathogenic Bacteria
por: Ashida, Hiroshi, et al.
Publicado: (2016)

Chromosome-encoded IpaH ubiquitin ligases indicate non-human enteroinvasive Escherichia
por: Dranenko, Natalia O., et al.
Publicado: (2022)

Peripheral Blood T Cells of Patients with IPAH Have a Reduced Cytokine-Producing Capacity
por: van Uden, Denise, et al.
Publicado: (2022)

Insights into the GSDMB-mediated cellular lysis and its targeting by IpaH7.8
por: Yin, Hang, et al.
Publicado: (2023)

Structural basis for GSDMB pore formation and its targeting by IpaH7.8
por: Wang, Chengliang, et al.
Publicado: (2023)

Cardiopulmonary exercise testing and pulmonary function testing for predicting the severity of CTEPH
por: Zhu, Hanqing, et al.
Publicado: (2021)

Pulmonary artery sarcoma presenting as chronic thromboembolic pulmonary hypertension (CTEPH)
por: Ampatzidou, Fotini, et al.
Publicado: (2023)

Stromal Expression of Heat-Shock Protein 27 Is Associated with Worse Clinical Outcome in Patients with Colorectal Cancer Lung Metastases
por: Schweiger, Thomas, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_85rgiid8uujj6uir9rsjqvm9du